Find therapies in clinical trials near you – page 2

Efficacy and safety of efgartigimod alfa in adults with Sjögren’s disease‑associated sensorimotor or sensory polyneuropathy: a phase 2 randomized placebo‑controlled study

Efficacy and safety of efgartigimod alfa in adults with Sjögren’s disease‑associated sensorimotor or sensory polyneuropathy: a phase 2 randomized placebo‑controlled study

Efficacy of efgartigimod alfa as first‑line add‑on to IV methylprednisolone for moderate‑to‑severe attacks in patients with demyelinating diseases

Study on Efgartigimod for Patients with Autoimmune Dementia

Study on Efgartigimod for Patients with Autoimmune Dementia

Study on the Effectiveness and Safety of Efgartigimod for Adults with Primary Sjögren's Syndrome

Study on the Effectiveness and Safety of Efgartigimod for Adults with Primary Sjögren's Syndrome

Safety Study of Efgartigimod in Adults with Primary Sjögren's Syndrome

Safety Study of Efgartigimod in Adults with Primary Sjögren's Syndrome

Study on the Effectiveness and Safety of Efgartigimod in Adults with Ocular Myasthenia Gravis

Study on the Effectiveness and Safety of Efgartigimod in Adults with Ocular Myasthenia Gravis

Safety and Efficacy Study of Efgartigimod PH20 Subcutaneous in Adults with Primary Immune Thrombocytopenia

Safety and Efficacy Study of Efgartigimod PH20 Subcutaneous in Adults with Primary Immune Thrombocytopenia

Study on the Effects and Safety of Efgartigimod PH20 SC for Adults with Active Idiopathic Inflammatory Myopathy

Study on the Effects and Safety of Efgartigimod PH20 SC for Adults with Active Idiopathic Inflammatory Myopathy

Study on the Effects of Efgartigimod Alfa for Patients with Generalized Myasthenia Gravis

Study on the Effects of Efgartigimod Alfa for Patients with Generalized Myasthenia Gravis

Study of Efgartigimod PH20 SC for Adults with Thyroid Eye Disease

Study of Efgartigimod PH20 SC for Adults with Thyroid Eye Disease

Study of Efgartigimod for Adults with Thyroid Eye Disease

Study of Efgartigimod for Adults with Thyroid Eye Disease

Study on Efgartigimod IV for Adults with Seronegative Generalized Myasthenia Gravis

Study on Efgartigimod IV for Adults with Seronegative Generalized Myasthenia Gravis